ve-s2r4p: antibody mediated prevention trial: where to from here?
Published 3 years ago • 262 plays • Length 1:30:06Download video MP4
Download video MP3
Similar videos
-
13:31
s2-07: vrc01 antibody prevention of hiv
-
58:40
ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
34:10
next-generation hiv prevention and therapy: antibody-based approaches
-
15:12
antibody mediated prevention of hiv - myron s. cohen, md, bs
-
57:36
ve-panel 3: novel scientific approaches to establish efficacy of new biologics for hiv prevention
-
58:08
ve-panel 2a: future design approaches for settings where all participants are on active prevention
-
2:59
gilead licenses hiv prevention drug to generic drugmakers
-
36:15
antibody mediated prevention of hiv
-
30:10
bnabs
-
1:16:52
hiv transmission workshop 2020_session 2_immune mediated prevention of hiv transmission
-
57:54
ve panel 1: design approaches for current and future hiv prevention efficacy trials
-
25:27
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 1/3)
-
1:29:54
hiv prevention and global health
-
12:25
monoclonal antibodies for hiv prevention - carlos del rio
-
1:00:23
antibody-mediated prevention: amp study
-
22:07
ias-usa hiv treatment guidelines: review of the 2020 update
-
1:02:07
ve-panel 3b: community engagement and involvement in hiv vaccine prevention clinical research
-
19:57
ias 2022 conference highlights